Carcinoma, Non-Small-Cell Lung: all 6,641 studies
Page 55 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.
- IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung TumorsTerminatedNCT01746810Phase 1
- Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs TherapyStatus unknownNCT01746277Phase 2
- Adjuvant Afatinib in Stage I-III NSCLC With EGFR MutationStatus unknownNCT01746251Phase 2
- Role of SPECT in Radiotherapy of Lung Cancer and Toxicity EvaluationCompletedNCT01745484Not applicable
- Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFRStatus unknownNCT01744925Phase 2
- Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLCStatus unknownNCT01742767Phase 2
- Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung CancerCompletedNCT01741636Not applicable
- Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)TerminatedNCT01741155Phase 2
- Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLCCompletedNCT01740804
- Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLCCompletedNCT01733589Phase 1/2
- Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung CancerWithdrawnNCT01731587Phase 1
- Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their CaregiversCompletedNCT01729689Not applicable
- A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic EvaluationWithdrawnNCT01728181Phase 1/2
- Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerCompletedNCT01727076Phase 1
- Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4TerminatedNCT01726309
- Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor CareCompletedNCT01726296Not applicable
- Icotinib or Whole Brain Irradiation in EGFR-mutant Lung CancerCompletedNCT01724801Phase 3
- ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating MutationsCompletedNCT01723878
- PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung CancerCompletedNCT01723800Phase 1
- Tarceva. ICORG 08-41CompletedNCT01721252
- Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung CancerTerminatedNCT01720186Not applicable
- Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC PatientsStatus unknownNCT01717105
- Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21Status unknownNCT01714908Phase 2
- A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]TerminatedNCT01714037Phase 1
- A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With CrizotinibCompletedNCT01712217Phase 1/2
- An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT01711697Phase 1
- Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage TherapyCompletedNCT01708993Phase 2
- VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung CancerStatus unknownNCT01707888
- Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerTerminatedNCT01707823Early Phase 1
- Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib TreatmentStatus unknownNCT01707329Phase 2
- Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.CompletedNCT01705184Phase 2
- A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic DiseaseWithdrawnNCT01702714Phase 1
- French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular TestingsCompletedNCT01700582
- Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung CancerCompletedNCT01700400Phase 1
- Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable DiseaseStatus unknownNCT01690390Phase 2
- Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung CancerStatus unknownNCT01688713Phase 2
- Lung Cancer Surgery: Decisions Against Life Saving Care - The InterventionCompletedNCT01687738Not applicable
- Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)CompletedNCT01687439Phase 2
- Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot StudyTerminatedNCT01685346Not applicable
- An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1)CompletedNCT01684111Phase 1
- An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2)CompletedNCT01683682Phase 1
- Erlotinib in Post Radical Operation NSCLC Patients With EGFR MutationStatus unknownNCT01683175Phase 2
- Survey on Chinese Medicine Syndrome for Patients With Non Small Cell Lung CancerTerminatedNCT01681485
- TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IVWithdrawnNCT01674738Phase 2
- Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT01669707Phase 2
- Photodynamic Therapy in Treating Patients With Lung CancerCompletedNCT01668823Phase 1
- Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung CancerCompletedNCT01666977Phase 1/2
- Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung CancerCompletedNCT01664754Phase 1
- Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With RadiochemotherapyTerminatedNCT01664663Phase 2
- BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and HematologyCompletedNCT01660776
- PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung CancerCompletedNCT01659970
- Circulating Tumor Cells in Lung CancerTerminatedNCT01658332Not applicable
- MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung CancerStatus unknownNCT01656551Phase 3
- Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung CancerCompletedNCT01652820Phase 2
- Afatinib Expanded Access ProgramApproved for marketingNCT01649284
- Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line ChemotherapyCompletedNCT01648517Phase 2
- Study of the Expression of Met Receptor Fragments in Non Small Cell Lung CancersCompletedNCT01647867Not applicable
- Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung CancerTerminatedNCT01647334Not applicable
- First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated PatientsStatus unknownNCT01646450Phase 4
- A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With CisplatinTerminatedNCT01641575Phase 1
- Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase TranslocationStatus unknownNCT01637597
- Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung CancerWithdrawnNCT01637376Phase 1
- Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung CarcinomaCompletedNCT01635270Phase 2
- Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT01633645Phase 2
- Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung CancerCompletedNCT01631357Phase 2/3
- Strategies for Maintenance Therapies in Advanced Non Small Cell Lung CancerCompletedNCT01631136Phase 3
- A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerCompletedNCT01630733Phase 3
- Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle AspiratesCompletedNCT01630122
- Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung CancerActive, not recruitingNCT01629498Phase 1/2
- MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung CancerCompletedNCT01628471Phase 1/2
- Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)CompletedNCT01620853
- Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung CancerStatus unknownNCT01619241
- Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung CancerTerminatedNCT01617980Not applicable
- 18F FLT Imaging Studies of Treatment Response for Lung Cancer and ThymomaWithdrawnNCT01610544Phase 2
- A Study of LY2875358 in Japanese Participants With Advanced CancerCompletedNCT01602289Phase 1
- An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)CompletedNCT01598597
- Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) TechnologyStatus unknownNCT01596452
- Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung CancerCompletedNCT01594398Phase 1
- Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung CancerStatus unknownNCT01593293Phase 3
- Phase II Study of S-488410 to Treat Non-small Cell Lung CancerStatus unknownNCT01592617Phase 2
- Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC PatientsCompletedNCT01588145Phase 1/2
- ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung CancerCompletedNCT01580735Phase 2
- Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung CancerStatus unknownNCT01579188Phase 3
- Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung CancerCompletedNCT01577654Phase 2
- Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)RadiotherapyTerminatedNCT01577212Phase 2
- Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung CancerStatus unknownNCT01576796Phase 2
- Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell CarcinomaStatus unknownNCT01574729Phase 2
- Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) NetworkTerminatedNCT01574300
- A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung CancerTerminatedNCT01574222Phase 1
- A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFRCompletedNCT01570296Phase 1
- Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung CancerTerminatedNCT01565772Phase 1
- Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ GulfCompletedNCT01562665
- Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT01562301Phase 1
- A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT01562015Phase 2
- Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the LungCompletedNCT01561456Phase 2
- A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung CancerCompletedNCT01560104Phase 2
- Tumor Associated Macrophage in Advanced Non-small Cell Lung CancerCompletedNCT01551251
- Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT01549093Phase 2
- Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung CancerCompletedNCT01545947Phase 1
- Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung CancerCompletedNCT01542437Phase 2